Regulatory tracker

Daily aggregated filings from FDA, DEA, SEC, CMS, and the Federal Register, filtered for mental health relevance.

August 28, 2026
CT
An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
research

Excessive Gestational Weight Gain, Pregnancy, INTUITIVE EATING, Perceived Stress, Prenatal Depression, Anxiety, Diet Quality, Physical Activity, Body Awareness — Intuitive Eating Intervention

View on ClinicalTrials.gov
CT
REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness
research

Major Depressive Disorder (MDD) — Rejoyn, Cognitive Behavioral Therapy (CBT) exercises

View on ClinicalTrials.gov
CT
Oral Thiamine (Vitamin B1) for Depression in Children and Adolescents
research

Major Depressive Disorder (MDD), Thiamine, Vitamin B1, Thiamine Diphosphate (TDP), Pediatrics — thiamine hydrochloride 100 mg

View on ClinicalTrials.gov
CT
Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV
research

PrEP Use — PrEPared Minds/ Mentes PrEParadas - Cognitive Behavioral Therapy, No Intervention

View on ClinicalTrials.gov
CT
Simulation-Based Subcutaneous Injection Training in Midwifery Students
research

Simulation Training, Midwifery Education, Subcutaneous Injection — Mannequin-Based Subcutaneous Injection Training, Peer-Based Subcutaneous Injection Training, Self-Based Subcutaneous Injection Training

View on ClinicalTrials.gov
CT
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
research

Post-Traumatic Stress Disorder, PTSD — Propranolol, Psychotherapy

View on ClinicalTrials.gov
CT
Psilocybin-Assisted Psychotherapy for Veterans With PTSD
psychedelics · research

Posttraumatic Stress Disorder (PTSD) — Psilocybin-assisted Psychotherapy

View on ClinicalTrials.gov
CT
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3
research

Opioid Abuse (Disorder), Clinical Decision Support — Refined EMBED CDS, Provider alert that nurse completed COWS

View on ClinicalTrials.gov
August 27, 2026
DEA
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
scheduling

On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement Administration

View on Federal Register
DEA
Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
scheduling

The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4- chlorobenzyl)piperidin-

View on Federal Register
CT
The Effects of a Caregiver-initiated Reading Intervention to Their Infant in the Neonatal Intensive Care Unit
research

Infant Admitted to Neonatal Intensive Care Unit (NICU) — Reading Intervention

View on ClinicalTrials.gov
CT
Progressive Muscle Relaxation and Kinesio Taping for Premenstrual Syndrome
research

Premenstrual Syndrome — Progressive Muscle Relaxation Exercise, Kinesio Taping

View on ClinicalTrials.gov
CT
Developing and Testing the Efficacy of AI-Chatbot-Based
research

Breast Cancer — AIAI-Chatbot CalmMindRecoveryJourney delivering BMS-MC therapy

View on ClinicalTrials.gov
CT
Using a School-Based Depression Literacy Psychoeducation Program With AI Chatbot to Improve Depression Literacy and Help-Seeking Among High School Students
research

Depressive Symptoms, Mental Health (Depression) — school-based depression literacy program

View on ClinicalTrials.gov
CT
Activating Voice Journaling for Mental Health With Voice Biomarkers
research

Depression / Major Depressive Disorder, Anxiety

View on ClinicalTrials.gov
CT
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
research

Risk of Depression and Anxiety — Partners in Parenting, Shamiri

View on ClinicalTrials.gov
CT
Sleep and Arterial Function in Hypertensive Patients With Poor Sleep Quality
research

Hypertension, Poor Sleep Quality, Insomnia, Arterial Stiffness — Behavioral: Cognitive-Behavioural Therapy for Insomnia (CBT-I), Passive sleep education

View on ClinicalTrials.gov
CT
Effect of Utilizing Virtual Reality With Pulmonary Rehabilitation on Depression in COPD Patients
research

COPD Patients, Depression in Chronic Obstructive Pulmonary Disease — virtual reality with pulmonary rehabilitation, controlled group received pulmonary rehabilitation without utilizing virtual reality

View on ClinicalTrials.gov
CT
THE EFFECT OF MINDFULNESS IN INFLAMMATION MARKERS (IL-6, TNF-Α, CRP AND CORTISOL) AMONG SURVIVORS OF TIDAL FLOODING IN SAYUNG DEMAK
research

Psychological Stress, Depression - Major Depressive Disorder, Anxiety, Inflammation, Disaster — Mindfulness Body Scan Training

View on ClinicalTrials.gov
CT
Enhanced Recovery Protocol Compliance and Quality of Recovery After Cesarean Delivery
research

Cesarean Section, Postoperative Recovery, Postoperative Pain — Assessment of Enhanced Recovery Protocol Compliance

View on ClinicalTrials.gov
CT
Passiflora Incarnata for Dental Extraction Anxiety
research

Dental Anxiety, Preoperative Anxiety — Passiflora incarnata extract, Placebo

View on ClinicalTrials.gov
CT
Mandala Coloring and Music for Cancer Fear and Screening Anxiety
research

Cancer Fear and Screening-Related Anxiety in Women Undergoing Cancer Screening — mandala, Music

View on ClinicalTrials.gov
CT
Predictors of Severe Postoperative Pain Within 24 Hours After Elective Cesarean Delivery Under Spinal Anesthesia
research

Cesarean Section, Postoperative Pain After Cesarean Section, Acute Pain — Observational Assessment of Postoperative Pain

View on ClinicalTrials.gov
CT
Evaluation of Community Health Worker Support to Help People With Serious Mental Illness to Quit Smoking
research

Nicotine Dependance, Serious Mental Illness, Smoking (Tobacco) Addiction, Tobacco Cessation, Community Health Workers, Cardiovascular (CV) Risk, Tobacco Use Disorder — Integrated CHW Support intervention, Enhanced usual care (EUC)

View on ClinicalTrials.gov
CT
Quit With Sense: Using Mindful Smoking and Wearable Device for Smoking Cessation
research

Smoking Cessation, Cigarette Smoking, Tobacco Use, Nicotine Dependence — Mindful Smoking and Sensor-Band Intervention, Smoking Cessation Information

View on ClinicalTrials.gov
CT
Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
research

Neuropsychiatric Symptom

View on ClinicalTrials.gov
CT
Unipolar Versus Bipolar Radiofrequency Ablation in Knee Osteoarthritis Pain
research

Bipolar Radiofrequency Ablation, Unipolar Radiofrequency Ablation, Knee Osteoarthritis, Pain — Unipolar radiofrequency ablation, Bipolar radiofrequency ablation

View on ClinicalTrials.gov
August 26, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
scheduling

The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever

View on Federal Register
DEA
Importer of Controlled Substances Application: Curia New York Inc.
scheduling

Curia New York Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
scheduling

Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
scheduling

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Experic LLC
scheduling

Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambrex Charles City
scheduling

Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
FDA
International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
scheduling

The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight drug subst

View on Federal Register
CT
Mandala Coloring and Resilience in Midwives
research

Psychological Resilience Among Midwives Working in Delivery Rooms — Mandala Coloring

View on ClinicalTrials.gov
CT
Family-authored Digital ICU Diary Intervention to Support Bereaved Family Members in Intensive Care Unit: A Pilot Mixed Methods Study
research

Bereavement — Family-authored Digital ICU Diary Intervention, Standard Care

View on ClinicalTrials.gov
CT
The Goal is to Examine the Impact of Doula-coordinated, Midwife-delivered Postpartum Care Among Individuals With Preterm Births <34 Weeks' Gestation Requiring NICU Admission.
research

Doula Support, Postpartum, Postpartum Anaemia, Postpartum Depression (PPD) — Doula-coordinated, Midwife-delivered postpartum care

View on ClinicalTrials.gov
CT
The Effect of Ostomy Care Education Applied With the Teach-Back Method to Ostomy-Opened Individuals on Self-Care Power, Ostomy Adjustment, and Anxiety
research

Ostomy - Ileostomy or Colostomy, Canser, Ileus, Intestinal Cancer — TEACH BACK METHOD

View on ClinicalTrials.gov
CT
Antenatal Bre-Lax Education for Perinatal Anxiety Reduction and Self-efficacy Among Pregnant Women in Karachi's Urban Slums
research

Perinatal Anxiety — Arm 2: BreLax Intervention Group 1, Arm 3: Combined Intervention Group 3

View on ClinicalTrials.gov
CT
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
research

Generalized Anxiety Disorder — SEP-363856

View on ClinicalTrials.gov
CT
Ukulele Music on Pain, Anxiety, and Postpartum Comfort
research

Postpartum — Live Ukulele Music

View on ClinicalTrials.gov
CT
The Effect of Simulation-Based Oxytocin Induction Training on Midwifery Students' Knowledge and Anxiety Levels
research

Simulation-based Midwifery Education, Oxytocin Induction — Theoretical Training on Oxytocin Induction, Simulation-Based Oxytocin Induction Training

View on ClinicalTrials.gov
CT
téléwork and Consumer Behavior: Longitudinal Study
research

Addictions — data collection

View on ClinicalTrials.gov
CT
Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase
research

Opioid Use Disorder — STORC

View on ClinicalTrials.gov
CT
Sensory and Physical Reactions to Beverage Cues
research

Alcohol Use Disorder (AUD) — Alcohol Cue Reactivity Paradigm

View on ClinicalTrials.gov
CT
NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
research

Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment — Perceptual Discrimination Training, Cognitive Control Training

View on ClinicalTrials.gov
CT
Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis
research

Clinical High Risk for Psychosis (CHR), Psychotic Disorders, Prodromal Symptoms — Active Intermittent Theta Burst Stimulation (BEAM-F3 Targeting), Sham Comparator: Sham iTBS

View on ClinicalTrials.gov
August 25, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
scheduling

Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
scheduling

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Chattem Chemicals
scheduling

Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
scheduling

Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc.
scheduling

Galephar Pharmaceutical Research Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute SRI Montana Satellite Laboratory
scheduling

Scottsdale Research Institute SRI Montana Satellite Laboratory has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc.
scheduling

Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Vici Health Sciences, LLC
scheduling

Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Biopharmaceutical Research Company
scheduling

Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Curia New York Inc
scheduling

Curia New York Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
scheduling

Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
CT
Early Detection of Perinatal Depression With Wearable Technology
research

Perinatal Depression — Oura Ring (Photoplethysmography-based wearable ring), EmbracePlus Watch (Electrodermal activity wristband sensor)

View on ClinicalTrials.gov
CT
Precision Closed-loop Brain-Computer Interface Neuromodulation for Treatment-Resistant Depression
research

Treatment-Resistant Major Depressive Disorder, Major Depressive Disorder — Closed-loop Deep Brain Stimulation (DBS), Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)

View on ClinicalTrials.gov
CT
A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
research

Outpatients or Inpatients With Depression — Shugan Jieyu Capsules

View on ClinicalTrials.gov
CT
Identifying Biomarkers of Response to Digital Interventions for Mood Disorders
research

Depression / Major Depressive Disorder, Bipolar Disorder (BD) — Online Cognitive Behavioural Therapy

View on ClinicalTrials.gov
CT
Individualized (fMRI-guided) TMS Intervention for PTSD
research

PTSD, Post Traumatic Stress Disorder (PTSD) — Active Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)

View on ClinicalTrials.gov
CT
Adjunctive Probiotic Therapy in Major Depressive Disorder: A Randomized Controlled Trial (ProMOOD)
research

Depression / Major Depressive Disorder — OMNi-BiOTiC® STRESS Repair, Matched Placebo Powder for Oral Solution

View on ClinicalTrials.gov
CT
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
research

Major Depression — TMS, NRX-101

View on ClinicalTrials.gov
CT
Effects of Online Laughter Yoga and Psychoeducation on Perceived Stress and Career Anxiety in Nursing Students
research

The Effect of Online Laughter Yoga Combined With Psychoeducation on Perceived Stress and Career Anxiety Among Nursing Students — Laughter Yoga Programme, Psychoeducational Programme

View on ClinicalTrials.gov
CT
Yintang Acupressure During Labor in Primiparous Women
research

Labor Pain, Anxiety — Yintang Acupressure, Sham Light Touch

View on ClinicalTrials.gov
CT
The Effect of Mandala Coloring, Sleep Quality, Anxiety With Premenstrual Syndrome
research

Premenstrual Syndrome — Mandala coloring group

View on ClinicalTrials.gov
CT
Varenicline as a Treatment for Cannabis Use Disorder
cannabis · research

Cannabis Abuse — Varenicline (Chantix), Placebo

View on ClinicalTrials.gov
CT
Chemokine Receptors on CD8+ T Cells in Patients With Bipolar Disorder
research

Bipolar Affective Disorders — CD8+ T-Cell Gene Expression Analysis

View on ClinicalTrials.gov
August 24, 2026
CT
Supported Online Self-Help for Veterans With Depression in Primary Care
research

Depression — Enhanced Usual Care (EUC), Supported Online Self-help for Depression (SOS-Depression)

View on ClinicalTrials.gov
CT
Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy
research

Major Depressive Disorder (MDD), Major Depressive Disorder With Psychotic Features — Lurasidone, Placebo, Background Antidepressant Therapy

View on ClinicalTrials.gov
CT
Action Observation and Motor Imagery Training in Cervical Disc Herniation
research

Cervical Disc Herniation, Chronic Pain, Kinesiophobia, Cervical Pain — Conventional Physiotherapy, Action Observation and Motor Imagery Training, Sham Observation

View on ClinicalTrials.gov
CT
40-Hz Audiovisual Stimulation in Schizophrenia Spectrum Disorders
research

Anxiety — 40-Hz Binaural Beat Music Combined With 40-Hz Rhythmic Photic Stimulation, Sham group

View on ClinicalTrials.gov
CT
Immersive Virtual Reality for Pain and Dental Anxiety During Pediatric Restorative Treatment
research

Dental Anxiety in Children, Dental Pain, Virtual Reality, Distraction, Dental Caries — Immersive Virtual Reality

View on ClinicalTrials.gov
CT
The Effect of Diaphragmatic Breathing Exercises Before Gastroscopy on Anxiety, Fear, and Vital Signs
research

Breath Exercise, State Anxiety, Adult Patients, Vital Signs Monitoring, Fear — Diaphragmatic Breathing Exercises

View on ClinicalTrials.gov
CT
Effectiveness of A Multi-Component Self-Management Intervention for Anxiety and Respiratory-Related Symptoms in Patients With Lung Cancer
research

Cancer — M-RDSI, RDSI, Usual Care

View on ClinicalTrials.gov
CT
Written Exposure in Substance Treatment (WEST 3.0): Randomized Controlled Trial
research

Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) — Written Exposure Therapy, Treatment as Usual

View on ClinicalTrials.gov
CT
Grappling With Trauma: Brazilian Jiu-Jitsu for First Responders
research

Post-traumatic Stress Disorder (PTSD), Trauma and Stress Related Disorders, Occupational Stress, Emotional Regulation Difficulties, Anger Problems, Relational Problems, Irritability — Brazilian Jiu-Jitsu Program

View on ClinicalTrials.gov
CT
Improving Quality of Informal Care for People With Schizophrenia
research

Schizophrenia — Dyadic Multicomponent Intervention (DMI), Dyadic Benefit-Finding Intervention (DBFI)

View on ClinicalTrials.gov
CT
Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia
research

Schizophrenia — xanomeline-trospium chloride, Oral antipsychotics

View on ClinicalTrials.gov
CT
Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia
research

Schizophrenia — Scaffolding-Based Board Game Intervention

View on ClinicalTrials.gov
August 21, 2026
CT
Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance
research

Behavioral Intervention, Nicotine Addiction — Standard phone call, phone call with MINDSPACE elements

View on ClinicalTrials.gov
CT
Personalized Addiction Treatment enHancement
research

Opioid Use Disorder, mHealth, Peer Support — Vira Platform, Treatment-As-Usual

View on ClinicalTrials.gov
CT
Tension-type Headache and Its Association
research

Tension-Type Headache, Sleep Disturbance, Smartphone Addiction, Quality of Life

View on ClinicalTrials.gov
CT
TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
research

Opioid Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe — TRTME

View on ClinicalTrials.gov
CT
How Does the Opioid System Shape Stress and Social Behaviour in Men and Women and What Role Does Childhood Unpredictability Play?
research

Stress, Early Life Stress, Sex Differences, Opioid — Morphine, Placebo

View on ClinicalTrials.gov
CT
Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment
research

Depression Disorder — Individualized resting-state functional connectivity-guided iTBS, Symptom-titrated algorithm-based longitudinal ECT (STABLE) algorithm

View on ClinicalTrials.gov
CT
DecNef for AVH in Schizophrenia
research

Schizophrenia Disorder, Schizoaffecitve Disorder — Decoded Neurofeedback

View on ClinicalTrials.gov
August 20, 2026
CT
IPV Prevention Among FDP
research

PTSD Symptoms, Violence Prevention, Depression and Anxiety Symptoms — EA$E-US, ongoing standard of care

View on ClinicalTrials.gov
CT
EMDR Grief Protocol for Traumatic Grief After Earthquake-Related Loss
research

Traumatic Grief, Post Traumatic Stress Disorder PTSD, Emotional Processing — EMDR Grief Protocol

View on ClinicalTrials.gov
CT
ONE-P TMS Military Veterans
research

PTSD - Post Traumatic Stress Disorder — D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS)

View on ClinicalTrials.gov
CT
Virtual Reality (VR)and Mobile-Based Smoking Cessation in Breastfeeding Mothers
research

Smoking Cessation, Tobacco Use Disorder, Breast Feeding — Virtual Reality and Mobile Application-Based Smoking Cessation Education

View on ClinicalTrials.gov
CT
Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
research

Pregnancy, Substance Use Disorder (SUD) — Contingency Management, Social Drivers of Health Screening

View on ClinicalTrials.gov
CT
Closed-loop TBS Targeting rPO for the Core Clinical Features of the Methamphetamine Use Disorder
research

Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity, Craving — Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO

View on ClinicalTrials.gov
CT
Group DBT Skills Training for First Episode Psychosis
research

Psychosis — group DBT

View on ClinicalTrials.gov
August 19, 2026
CT
ONE-P TMS First Responders
research

PTSD - Post Traumatic Stress Disorder — D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS)

View on ClinicalTrials.gov
CT
Evaluation of a Modularized Cognitive Behavioral Group Therapy Programme for Young Adults (CHANGE-Study)
research

Psychiatric Disorder — CHANGE - modularized group psychotherapy

View on ClinicalTrials.gov
CT
Short-Term Psychodynamic Group Therapy for Problematic Pornography Use
research

Addiction — Short-Term Psychodynamic Group Therapy

View on ClinicalTrials.gov
CT
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
research

Alcohol Use Disorder (AUD), Obesity (BMI Equal to or >30) — Placebo, Semaglutide 1.0 mg, Semaglutide 2.0 mg

View on ClinicalTrials.gov
CT
Psilocybin for Methamphetamine Use Disorder
psychedelics · research

Methamphetamine Use Disorder — Psilocybin (single oral capsule administered at one of two dose levels, Dose A or Dose B; specific doses withheld during conduct)., Manualized cognitive behavioral therapy platform (2 preparation + 2 integration sessions).

View on ClinicalTrials.gov
CT
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)
research

Schizophrenia — Active rTMS, Strong Cognitive Training, Sham rTMS

View on ClinicalTrials.gov
CT
Efficacy and Safety of Temporal Interference Stimulation in Treatment-Resistant Schizophrenia: An Exploratory Study.
research

Treatment-resistant Schizophrenia — Temporal Interference Stimulation

View on ClinicalTrials.gov
August 18, 2026
CT
The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD
research

PTSD, Posttraumatic Stress Disorder — methylphenidate (Ritalin®), Reboxetine, Placebo

View on ClinicalTrials.gov
CT
Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior
research

HIV, Risk Behavior, Alcohol Abuse — CLT- Concrete text messages, CLT- Abstract text messages, Control messages

View on ClinicalTrials.gov
CT
Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder
research

Opioid Use Disorder, Tobacco Use Disorder — Deep TMS System With H4 Coil

View on ClinicalTrials.gov
CT
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
research

Schizophrenia Disorder, Metabolic Syndrome, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance — Semaglutide + TAU, Placebo + TAU

View on ClinicalTrials.gov
CT
Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
research

SCHIZOPHRENIA 1 (Disorder) — physiotherapy, 2 x a week for 6 weeks, basal therapy, 2 x a week for 6 weeks, Standard therapy group

View on ClinicalTrials.gov
CT
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
research

Major Depressive Disorder (MDD)

View on ClinicalTrials.gov
August 17, 2026
CT
EEG and Actigraphy Biomarkers of Written Exposure Therapy for Posttraumatic Stress Disorder
research

Posttraumatic Stress Disorder (PTSD) — Written Exposure Therapy, Neutral Writing Condition

View on ClinicalTrials.gov
CT
Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories
research

Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s) — Unconscious Trauma Reactivation plus Eye Movements, Active Trauma Memory Reactivation plus Eye Movements, Neutral Memory Reactivation plus Eye Movements

View on ClinicalTrials.gov
CT
Real-time Opioid Study
research

Substance Use Disorder (SUD) — real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback

View on ClinicalTrials.gov
CT
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
research

Schizophrenia, Antipsychotic Drug — Xingqi Daozhi Decoction, Placebo Group

View on ClinicalTrials.gov
CT
Project MOVE Bipolar
research

Bipolar Disorder (BD) — BA, SHE, HE

View on ClinicalTrials.gov
August 14, 2026
DEA
Exempt Chemical Preparations Under the Controlled Substances Act
scheduling

The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through Jun

View on Federal Register
CT
NEST: A Group Intervention for Parents With Complex PTSD
research

Complex Post-Traumatic Stress Disorder — Trauma-Informed Parenting Group Intervention

View on ClinicalTrials.gov
CT
MDMA-AT for PTSD in Young Adults With Childhood Trauma
psychedelics · research

Posttraumatic Stress Disorder (PTSD) — MDMA assisted psychotherapy

View on ClinicalTrials.gov
August 12, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
scheduling

The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and e

View on Federal Register
CT
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)
research

Written Exposure Therapy — Written Exposure Therapy (WET)

View on ClinicalTrials.gov
CT
Study of rTMS in Maintenance in Treatment Resistant Depression
research

Treatment Resistant Depression (TRD) — Transcranial Magnetic Stimulation, quetiapine

View on ClinicalTrials.gov
CT
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
research

SCHIZOPHRENIA 1 (Disorder) — HS-10380

View on ClinicalTrials.gov
CT
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
research

Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms — Deferiprone (DFP), N-Acetyl Cysteine (NAC)

View on ClinicalTrials.gov
August 11, 2026
DEA
Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
scheduling

The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)- N-(5-fluoropyri

View on Federal Register
CT
The Many Roads to Trauma Recovery: A Clinical Trial Comparing Empirically Supported Treatments for Veterans With Co-Morbid Posttraumatic Stress and Substance Use Disorder Symptoms
research

Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) — Trauma Informed Heart Rate Variability Biofeedback, Present Centered Therapy

View on ClinicalTrials.gov
CT
Intergenerational Risk and Resilience of Rohingya in Displacement
research

Child Development, Early Child Development, Mental Health, PTSD - Post Traumatic Stress Disorder, Intergenerational Trauma, Refugee Health

View on ClinicalTrials.gov
CT
Impact of De Quervain's Tenosynovitis on Grip Strength and Quality of Life in Smartphone-Addicted Adolescents
research

Hand Grip Strength, Quality of Life

View on ClinicalTrials.gov
CT
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
psychedelics · research

Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) — Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support

View on ClinicalTrials.gov
CT
One-Day cTBS Over the Precuneus
research

Depressive Disorder, Treatment-Resistant, Treatment Resistant Depression (TRD), Treatment Resistant Major Depression Disorder — Precuneus-targeted continuous theta-burst stimulation, Left dorsolateral prefrontal cortex intermittent theta-burst stimulation, Sham transcranial magne

View on ClinicalTrials.gov
CT
Simulation-Based Schizophrenia Training in Nursing Education
research

SCHIZOPHRENIA 1 (Disorder), Simulation Based Learning, Nursing Students — Simulation

View on ClinicalTrials.gov
CT
Aerobic, Resistance and Inspiratory Muscle Training in Adults With Severe Mental Disorder
research

Severe Mental Disorder — Supervised multicomponent exercise programme

View on ClinicalTrials.gov
August 10, 2026
CT
Effects of Very Low Nicotine Content Cigarettes Among Adults Who Smoke Daily in South Korea
research

Cigarette Smoking, Nicotine Dependence — SPECTRUM cigarettes, SPECTRUM cigarettes

View on ClinicalTrials.gov
CT
Repetitive Transcranial Magnetic Stimulation for Alcohol Use Disorder
research

Alcohol Use Disorder (AUD), Alcoholism — Repetitive transcranial magnetic stimulation

View on ClinicalTrials.gov
CT
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
research

Schizophrenia, Schizoaffecitve Disorder — Digital therapeutic (AffectUs), Psychoeducational materials

View on ClinicalTrials.gov
CT
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
research

Clinical High Risk for Psychosis (CHR), Suicidal Ideation, Psychosis, Suicidal Behavior — Suicide Prevention Intervention, Standard Care (in control arm)

View on ClinicalTrials.gov
August 6, 2026
CT
Effectiveness of Acceptance and Commitment Therapy in Promoting Mental Health of Emerging Adults With Internet Addiction
research

Internet Addiction — Acceptance and Commitment Therapy (ACT)

View on ClinicalTrials.gov
CT
Reducing Opioid Use After Upper Extremity Surgery: Testing Lower Prescriptions and Pill Quantity
research

Opioid Abuse (Disorder), Opioid Analgesia, Opioid Analgesic Adverse Reaction, Opioid Consumption — Naproxen, Acetaminophen, oxycodone

View on ClinicalTrials.gov
CT
Comparison Between Traditional Bipolar Radiofrequency and Cooled Radiofrequency in Sacroiliac Joint Pain Patients
research

Sacroiliac Joint Pain — Traditional bipolar radiofrequency, Cooled radiofrequency

View on ClinicalTrials.gov
CT
Hydrodissection-Assisted Bipolar Prostatic Enucleation Versus Conventional Bipolar Enucleation
research

Prostatic Hyperplasia, Lower Urinary Tract Symptoms — Hydrodissection-Assisted Bipolar Prostatic Enucleation-Enucleoresection, Conventional Bipolar Prostatic Enucleation-Enucleoresection

View on ClinicalTrials.gov
CT
Examining Lithium's Mechanism in Bipolar Disorder
research

Healthy, Bipolar — Lithium carbonate (Priadel), Controlled light exposure

View on ClinicalTrials.gov
CT
Enhancing Resilience and Quality of Life in Bipolar Disorder Through Cognitive Behavioral Therapy
research

Bipolar Affective Disorder; Remission in — CBT-Based Psychological Resilience Enhancement Program for Individuals with BD

View on ClinicalTrials.gov
August 5, 2026
CT
PTSD Risk Prediction Model for EICU Survivors
research

Post-traumatic Stress Disorder (PTSD)

View on ClinicalTrials.gov
CT
Recovery Opportunities Through Ongoing Treatment Sustainment
research

Substance Use Disorders (SUDs) — Youth Substance Use Unit

View on ClinicalTrials.gov
CT
EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT
research

Major Depression Moderate, Major Depression Severe, Major Depression With Comorbid Anxiety Symptoms, Major Depression With Panic Attacks, Major Depression With Psychotic Features, Major Depressive Episode, Major Depressive Disorder (MDD, Major Depression — Electroconvulsive Thera

View on ClinicalTrials.gov
CT
The Effect of Combined Brain Stimulation and Yoga for Improving Cognitive Function in Psychosis
research

Cognitive Functioning, Psychosis — Active tDCS, Sham tDCS, Yoga

View on ClinicalTrials.gov
CT
Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia
research

SCHIZOPHRENIA 1 (Disorder), Alcohol Use Disorder, Alcohol Dependence (Primary Condition) — Snoezelen® therapy for 6 weeks, Snoezelen® therapy for 12 weeks

View on ClinicalTrials.gov
August 4, 2026
CT
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
psychedelics · research

PTSD, PTSD - Post Traumatic Stress Disorder, Major Depression, Suicidality — Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback

View on ClinicalTrials.gov
CT
Supportive Treatment With Enhanced Post-Incarceration Services
research

Substance Use Disorders (SUDs) — Individually Tailored Behavioral Activation, Formerly Incarcerated Transitions Program

View on ClinicalTrials.gov
CT
Developing Biomarker-Supported Schizophrenia Spectrum Disorder (SSD) Prevention
research

Prevention, Risk Factors for Mental Illness, Family History of Schizophrenia Spectrum Disorder — Psychosocial intervention group

View on ClinicalTrials.gov
CT
An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)
research

Bipolar 1 Disorder, Schizophrenia Disorder — OLZ/SAM

View on ClinicalTrials.gov
CT
The Effect of Combined Brain Stimulation and Exercise for Improving Cognitive Function in Schizophrenia
research

Schizophrenia, Cognitive Functions — Aerobic exercise, Active tDCS, Sham tDCS

View on ClinicalTrials.gov
CT
Safety and Feasibility of DBS for Bipolar Depression
research

Bipolar I Disorder, Bipolar Depression — Medtronic Percept PC DBS system

View on ClinicalTrials.gov
August 3, 2026
DEA
Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
scheduling

The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as

View on Federal Register
CT
Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to Treatment
research

Schizophrenia, Treatment Resistant Depression (TRD), Bipolar Disorder (BD), Catatonia, Obsessive Compulsive Disorder (OCD) — Blood sampling, lumbar puncture, stool sampling, skin microbiopsy and psychometrics scales

View on ClinicalTrials.gov
July 31, 2026
CT
Early Addiction Care Pathway After Acute Drug Intoxication in Emergency Departments
research

Intoxication; Opioid — Structured early addiction care, Not structured early addiction care

View on ClinicalTrials.gov
CT
Tirzepatide Impact Assessment Study
research

Obesity & Overweight, Cardiometabolic Health Indicators, Addiction, Eating Disorders, Mental Health — GLP-1 Receptor Agonist Therapy, Structured Lifestyle Intervention

View on ClinicalTrials.gov
CT
Connecting Loved Ones to Support and Empowering Recovery
research

Substance Use Disorder (SUD), mHealth — KulaMind-Recovery

View on ClinicalTrials.gov
CT
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
research

Major Depression Moderate, Major Depression Severe, Major Depression With Comorbid Anxiety Symptoms, Major Depression With Panic Attacks, Major Depression With Psychotic Features, Major Depressive Episode, Bipolar Affective Disorder, Bipolar Depression Depressed Phase, Bipolar De

View on ClinicalTrials.gov
CT
Treatment of Aging Signs of the Skin With Bipolar Radiofrequency
research

Wrinkles and Rhytides

View on ClinicalTrials.gov
July 30, 2026
CT
Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders
research

Depression, Anxiety, Substance Use Disorder (SUD), Post Traumatic Stress Disorder — Microcurrent Neurofeedback (MCN), Standard Care for Substance Use Disorder

View on ClinicalTrials.gov
CT
Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD
psychedelics · research

Post-Traumatic Stress Disorder, PTSD — Psilocybin (drug), Trauma-Focused Psychotherapy

View on ClinicalTrials.gov
CT
Acute Effects of Estradiol Administration on Brain Function During Fear Learning
research

PTSD and Trauma-related Symptoms, Cognitive Decline in Older Adults, Post Menopausal Women — estradiol

View on ClinicalTrials.gov
CT
A Novel Adaptation of the Unified Protocol (UP) as a Transdiagnostic Intervention for Emotional Disorders in Addictive Behaviors
research

Addictive Behaviors, Emotion Regulation — Transdiagnostic cognitive-behavioral therapy, Treatment as usual

View on ClinicalTrials.gov
CT
Repetitive Transcranial Magnetic Stimulation for People With Etomidate Addiction (SToP-E-rTMS x Etomidate)
research

Etomidate Use Disorder, Repetitive Transcranial Magnetic Stimulation (rTMS) — high-frequency Repetitive Transcranial Magnetic Stimulation, Repetitive transcranial magnetic stimulation

View on ClinicalTrials.gov
CT
EFFECTIVENESS OF SOLUTION-FOCUSED APPROACH-BASED PSYCHOEDUCATION IN INDIVIDUALS DIAGNOSED WITH SUBSTANCE USE DISORDER: A RANDOMIZED CONTROLLED TRIAL
research

Addiction, Theraphy — psychoeducation

View on ClinicalTrials.gov
CT
Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression
psychedelics · research

Treatment-resistant Depression (TRD) — Group integration therapy

View on ClinicalTrials.gov
July 29, 2026
CT
Self-Compassion, Health, and Empowerment
research

Intimate Partner Violence (IPV), Depression and/or Anxiety Symptoms, PTSD - Post Traumatic Stress Disorder — The Self-Compassion, Health, and Empowerment (SHE) Intervention, Health and Nutrition Program

View on ClinicalTrials.gov
CT
Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.
research

Addiction — Observational assessments (EMA and annual DSM-5 evaluations)

View on ClinicalTrials.gov
CT
Testing a New Gold Nanoparticle-Based Lithium Delivery Method for Bipolar Disorder in Laboratory Models
research

Bipolar Disorder (BD), Bipolar Disorder (BPD) — Peripheral blood sampling for PBMC isolation

View on ClinicalTrials.gov
CT
Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes
research

Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate — TURP, Epinephrine

View on ClinicalTrials.gov
CT
The Effect of Cognitive Behavioral Psychoeducation on Internalized Stigma in Individuals With Bipolar Disorder
research

Bipolar Disorder (BD), Internalized Stigma, Psychoeducation — Cognitive-behavioral based psychoeducation program, Standard Care (in control arm)

View on ClinicalTrials.gov